Novartis AG

NVS· NYSE· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$153.70-1.57%

2026-08-03

Financials

Valuation Metrics

Novartis AG's Market Cap is $293.27B. At end of 2025 it was $263.75B. Ranked #44 of 3,112 in US market (top 1%), #24 of 1,667 on NYSE (top 1%), #5 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 2%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$293.27B	US#44/3,112 Sec#5/269
Revenue	$56.05B	US#125/3,112 Sec#7/269
Net Income	$13.53B	US#42/3,112 Sec#4/269
Total Assets	$118.53B	US#156/3,112 Sec#6/269
Net Assets	$38.51B	US#123/3,112 Sec#7/269
Value
P/E	21.67x	US#1,115/3,112 Sec#40/269
P/B	7.62x	US#2,465/3,112 Sec#183/269
P/S	5.23x	US#2,309/3,112 Sec#82/269
EV/EBITDA	14.88x	US#1,471/3,112 Sec#45/269
FCF Yield	5.58%	US#1,168/3,112 Sec#43/269
Profitability
ROE	35.14%	US#219/3,112 Sec#23/269
ROA	11.42%	US#355/3,112 Sec#32/269
Op. Margin	30.54%	US#427/3,112 Sec#23/269
Revenue Growth	-0.70%	US#2,289/3,112 Sec#127/269
Earnings Growth	-12.48%	US#1,572/3,112 Sec#48/269
Financial Health
Debt Ratio	206.70%	US#1,827/3,112 Sec#203/269
Total Debt	$47.00B	US#97/3,112 Sec#6/269
FCF	$16.36B	US#36/3,112 Sec#3/269
Cash	$6.88B	US#155/3,112 Sec#7/269
Current Ratio	0.85x	US#2,433/3,112 Sec#267/269
Net Debt/EBITDA	1.79x	US#1,308/3,112 Sec#57/269
Dividend
Div. Yield	2.97%	US#581/3,112 Sec#7/269
Div. Growth	3.07%	US#968/3,112 Sec#15/269
Performance
1Y Return	33.30%	US#1,191/3,112 Sec#145/269
1M Return	-3.88%	US#2,127/3,112 Sec#114/269
From 52W High	-9.83%	US#1,031/3,112 Sec#50/269
1Y MDD	-15.23%	US#321/3,112 Sec#11/269
Trading
Volume	1,578,309 shares	US#1,081/3,112 Sec#98/269
Trading Value	$244M	US#444/3,112 Sec#21/269
Per Share
EPS	$7.31	US#395/3,112 Sec#13/269
BPS	$24.11	US#1,052/3,112 Sec#24/269